EORTC-24954-HNCG-ROG

Phase III study on larynx preservation comparing induction chemotherapy and radiotherapy versus alternating chemo-radiotherapy in resectable hypopharynx and larynx cancers (Jointly with the EORTC Radiotherapy Cooperative Group)
Trial StatusFurther follow-up after final analysis of primary endpoint
DatesDate of activation: 23-Jul-96
Closed on : 15-May-04
Data management at EORTCFull
Phase3
Randomized trialYes
TypeNeoadjuvant
Targeted Sample size564
Number of steps1
Drug
Study StaffJean-Claude Horiot
Study Coordinator - Clinique De Genolier, Genolier
Jean-Louis Lefebvre
Study Coordinator - Centre Oscar Lambret, Lille
Livia Giurgea
Data Manager - EORTC Headquarters, Brussels
livia.giurgea (at) eortc.be - +32 27741692
Jessica Menis
Coordinating Physician - EORTC Headquarters, Brussels
Leslie Herman
Project Manager - EORTC Headquarters, Brussels
leslie.herman (at) eortc.be - +32 27741511
Type of cancerHead and Neck
Participating GroupsEORTC Head and Neck Cancer Group(Coordinating Group)
EORTC Radiation Oncology Group
Protocol summaryClinicalTrials.gov
NCT numberNCT00002839
EudraCT